Director/PDMR Shareholding

RNS Number : 3770G
Conygar Investment Company PLC(The)
24 November 2020
 

24 November 2020

 

The Conygar Investment Company PLC

 

Director/PDMR Shareholding

 

The Conygar Investment Company PLC ("Conygar" or "Company"), the property investment and development group, announces that it has been notified today that Robert Ware, Chief Executive Officer of the Company, transferred 884,000 ordinary shares in the capital of the Company, of which 789,000 were transferred to his SIPP and 95,000 were transferred to his ISA. Following the transfer, Robert Ware still holds 4,602,500 ordinary shares, representing 8.6% of the existing issued share capital of the Company.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Robert Ware

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

The Conygar Investment Company PLC

b)

 

LEI

 

213800WAVVOPS85N2205

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 5p each

 

ISIN: GB0033698720

b)

 

Nature of the transaction

 

 

Transfer from Nominee to Personal SIPP and Personal ISA

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£0.98

789,000

£0.98

95,000

d)

 

Aggregated information

 

 

- Aggregated volume

- Price

 

Price(s)

Volume(s)

£0.98

884,000

 

e)

 

Date of the transaction

 

24 November 2020

f)

 

Place of the transaction  

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLBDBIDDDGGS
UK 100

Latest directors dealings